Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020; 22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004. Case and Commentary Mar 2022 Why Professionalism Demands Abolition of Carceral Approaches to Patients’ Nonadherence Behaviors Nhi Tran, MD, MPH, Aminta Kouyate, and Monica U. Hahn, MD, MPH, MS Patients’ adherence to recommendations can unjustly influence their candidacy for a current intervention. AMA J Ethics. 2022; 24(3):E181-187. doi: 10.1001/amajethics.2022.181. Medicine and Society Mar 2022 Narrative, Compassion, and Counter Stories Aleksandra E. Olszewski, MD, MA Critical race theory tools of evaluating stock characters and counter stories can help clinicians and researchers illuminate experiences of those at the margins. AMA J Ethics. 2022; 24(3):E212-217. doi: 10.1001/amajethics.2022.212. Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022; 24(3):E226-232. doi: 10.1001/amajethics.2022.226. Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022; 24(4):E296-304. doi: 10.1001/amajethics.2022.296. Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019; 21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019; 21(7):E575-581. doi: 10.1001/amajethics.2019.575. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019; 21(7):E600-602. doi: 10.1001/amajethics.2019.600. Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022; 24(5):E368-375. doi: 10.1001/amajethics.2022.368. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Next page Next › Last page Last »
Case and Commentary Dec 2020 Should a Patient Who Is Pregnant and Brain Dead Receive Life Support, Despite Objection From Her Appointed Surrogate? Daniel Sperling, SJD Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base. AMA J Ethics. 2020; 22(12):E1004-1009. doi: 10.1001/amajethics.2020.1004.
Case and Commentary Mar 2022 Why Professionalism Demands Abolition of Carceral Approaches to Patients’ Nonadherence Behaviors Nhi Tran, MD, MPH, Aminta Kouyate, and Monica U. Hahn, MD, MPH, MS Patients’ adherence to recommendations can unjustly influence their candidacy for a current intervention. AMA J Ethics. 2022; 24(3):E181-187. doi: 10.1001/amajethics.2022.181.
Medicine and Society Mar 2022 Narrative, Compassion, and Counter Stories Aleksandra E. Olszewski, MD, MA Critical race theory tools of evaluating stock characters and counter stories can help clinicians and researchers illuminate experiences of those at the margins. AMA J Ethics. 2022; 24(3):E212-217. doi: 10.1001/amajethics.2022.212.
Medicine and Society Mar 2022 How Abolition of Race-Based Medicine Is Necessary to American Health Justice Stephen P. Richmond II, MD, MPH and Vanessa Grubbs, MD, MPH Medicine has always maintained social, political, and economic structures that have exacerbated Black and Brown persons’ lived embodiment of racism. AMA J Ethics. 2022; 24(3):E226-232. doi: 10.1001/amajethics.2022.226.
Medicine and Society Apr 2022 Recognizing and Dismantling Raciolinguistic Hierarchies in Latinx Health Pilar Ortega, MD, Glenn Martínez, PhD, MPH, Marco A. Alemán, MD, Alejandra Zapién-Hidalgo, MD, MPH, and Tiffany M. Shin, MD Raciolinguistic hierarchies can undermine the quality of Latinx patients’ health experiences. AMA J Ethics. 2022; 24(4):E296-304. doi: 10.1001/amajethics.2022.296.
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019; 21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019; 21(7):E575-581. doi: 10.1001/amajethics.2019.575.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019; 21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Case and Commentary May 2022 How Does Cognitive Bias Affect Conversations With Patients About Dietary Supplements? Ila M. Harris, PharmD, Christine C. Danner, PhD, and David J. Satin, MD Some allopathic clinicians’ biases influence the information they draw upon to make decisions and offer recommendations. AMA J Ethics. 2022; 24(5):E368-375. doi: 10.1001/amajethics.2022.368.